Dr. Annaliesa S. Anderson Pfizer Vaccine Research and Development, USA

Annaliesa S. Anderson, PhD, FAAM, has over 20 years of pharmaceutical research experience and is currently the Vice President and Chief Scientific Officer for both the Bacterial Vaccines within the Vaccine Research and Development Unit and The Hospitals Business Unit at Pfizer Inc. Dr. Anderson’s experience includes leadership roles for... read morebacterial vaccine programs directed at the prevention of diseases due to Streptococcus pneumoniae, Neisseria meningitidis, Staphylococcus aureus, Clostridium difficile and Group B Streptococcus. She has made substantial contributions to vaccine antigen discovery, preclinical proof of concept, clinical proof of concept, and vaccine licensure. Dr. Anderson earned her doctorate in biological sciences at the University of Warwick, England, in the field of microbial ecology and then completed two post-doctoral fellowships. Prior to joining Pfizer, Dr. Anderson worked at Merck Research Laboratories in Rahway, NJ.